Deal Making

Featured on Deal Making

Synaffix strikes ADC licensing deal with Sotio
Deal-Making
Synaffix strikes ADC licensing deal with SotioSynaffix strikes ADC licensing deal with Sotio

Sotio will use Synaffix’s antibody-drug conjugate (ADC) platform to develop up to three products targeting tumor-associated antigens.

More from Deal Making